59 filings
8-K
REVB
Revelation Biosciences Inc
10 May 24
Results of Operations and Financial Condition
4:57pm
8-K
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
8-K
REVB
Revelation Biosciences Inc
11 Mar 24
Regulation FD Disclosure
9:53pm
8-K
REVB
Revelation Biosciences Inc
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
8-K
REVB
Revelation Biosciences Inc
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
8-K
tk7a7 rt8s
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
0fvji
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
nxiwkf1ph561606w 1u
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
ljannwc9p6 a8vuqng
12 Oct 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2023 www.revbiosciences.com
4:26pm
8-K
b4yvnyg
2 Oct 23
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
4:24pm
8-K
vi5bfy1sm3w3l2 23qdl
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
am1lnu 4rcy09tuotead
11 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
a9ygczxyox65sh3j
14 Jul 23
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
ghv9chd8mm3x9deb25tz
7 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
1qpqa6 5j
29 Jun 23
Regulation FD Disclosure
4:23pm
8-K
7jh yt2pv
12 Jun 23
Regulation FD Disclosure
4:20pm
8-K
lh8gwll
25 May 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / May 2023 www.revbiosciences.com
4:32pm
8-K
msdqk10c8
22 May 23
Results of Operations and Financial Condition
1:22pm
8-K
k72zh 9ehdvsiyb
3 Apr 23
Results of Operations and Financial Condition
4:33pm
8-K
icg0yr pdc
17 Feb 23
Other Events
4:13pm